Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation

Diabetes

Volumn 50, Issue 2, 2001, Pages 270-276

  Molano, R Damaris ^a   Berney, Thierry ^a   Li, Hua ^a   Cattan, Pierre ^a   Pileggi, Antonello ^a   Vizzardelli, Caterina ^a   Kenyon, Norma S ^a   Ricordi, Camillo ^a   Burkly, Linda C ^b   Inverardi, Luca ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GLYCOPROTEIN GP 39; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MR 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; INSULIN DEPENDENT DIABETES MELLITUS; ISOGRAFT; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT OUTCOME;

EID: 0035145720     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.2.270     Document Type: Article

References (35)

1. Islet transplantation in seven patients with type 1 diabetes melitus using a glucocorticoid-free immunosuppressive regimen
2. Current indications and limits of pancreatic islet transplantation in diabetic nephropathy
3. A cell culture model for T lymphocyte clonal anergy
4. Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy
5. In vitro induction of T cell anergy by blocking B7 and early T cell costimulatory molecule ETC-1/B7-2
6. Costimulation and its role in organ transplantation
7. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig
8. Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation
9. Molecular and biological characterization of a murine ligand for CD40
10. Anti-CD154 therapy to prevent graft rejection
11. Stimulation of CD40 with profiled soluble gp39 induces proinflammatory responses in human monocytes
12. CD40 ligand stimulates proinflammatory cytokine production by human endothelial cells
13. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40
14. The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells
15. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis
16. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis
17. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice
18. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand
19. Induction of immunological tolerance to islet allografts
20. Prolonged survival of rat islet and skin xenografts in mice treated with donor splenocytes and anti-CD154 monoclonal antibody
21. Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154
22. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154
23. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in non-human primates
24. NOD mice have a generalized defect in their response to transplantation tolerance induction
25. Induction of donor-specific tolerance to rat islets allografts by intrathymic inoculation of solubilized spleen cell membrane antigens
26. The CD40 pathway in allograft rejection, acceptance, and tolerance
27. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes
28. Murine macrophages and pancreatic β-cells
29. Repetitive exposure of pancreatic islets to interleukin-1 beta: An in vitro model of pre-diabetes?
30. Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets
31. + T-cell clones in vivo
32. Prevention of T-cell activation by rhCTLA4-Ig and AntiCD40L monoclonal antibody results in indefinite islet graft survival
33. CD40-gp39 interactions play a critical role during allograft rejection by blockade of the CD40-gp39 pathway
34. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and antiCD154 monoclonal antibody treatment
35. NOD mouse colonies around the world-recent facts and figures